TC14012 TFA;
TC14012 TFA 是 T140 的血清稳定衍生物，是一种选择性的 CXCR4 拮抗剂，IC50 为 19.3 nM。TC14012 TFA 是有效的 CXCR7 激动剂，可将 β-arrestin2 募集到 CXCR7，EC50 为 350 nM。TC14012 TFA 具有抗 HIV 活性和抗癌活性。
TC14012 TFA Chemical Structure
| 规格 | 是否有货 | ||
|---|---|---|---|
| 100 mg | ; | 询价 | ; |
| 250 mg | ; | 询价 | ; |
| 500 mg | ; | 询价 | ; |
* Please select Quantity before adding items.
TC14012 TFA 的其他形式现货产品:
| 生物活性 |
TC14012 TFA, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 TFA is a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 TFA has anti-HIV activity and anti-cancer activity[1][2]. |
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IC50 Target[1][2] |
|
||||||||||||||||||||
| 体外研究 (In Vitro) |
TC14012 TFA (1 mM) inhibits more than 95% the infection of the CXCR4-expressing cells by the HXB2 (X4) or 89.6 (dual-tropic) strain whereas TC14012 TFA (1 mM) does not inhibit all the infection of the CCR5-expressing cells by the SF162 (R5) or 89.6 (dualtropic) strain[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||||||
| 分子量 |
2180.44 |
||||||||||||||||||||
| Formula |
C92H141F3N34O21S2 |
||||||||||||||||||||
| Sequence Shortening |
RR-{2Nal}-CY-{Cit}-K-{Cit}-PYR-{Cit}-CR-NH2 (Disulfide bridge:Cys4-Cys13) |
||||||||||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||||||
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
||||||||||||||||||||
| Solvent Solubility |
In Vitro:;
H2O Peptide Solubility and Storage Guidelines: 1.;;Calculate the length of the peptide. 2.;;Calculate the overall charge of the entire peptide according to the following table:
3.;;Recommended solution:
|
||||||||||||||||||||
| 参考文献 |
|
